Navigation Links
CORD:USE Cord Blood Bank Receives Prestigious Accreditation from the Foundation for the Accreditation of Cellular Therapy
Date:1/22/2009

ORLANDO, Fla., Jan. 22 /PRNewswire/ -- CORD:USE Cord Blood Bank is honored to announce that it has been accredited by the Foundation for the Accreditation of Cellular Therapy ("FACT"). CORD:USE is a leading public cord blood bank that specializes in the collection, processing, storage and distribution of donated cord blood. Cord blood has already been used for transplantation in more than 14,000 patients with over 70 life-threatening diseases such as leukemia, lymphoma, thalassemia, and sickle cell anemia.

"The Accreditation by FACT is an important milestone for CORD:USE," says Dr. Edward Guindi, President and CEO of CORD:USE Cord Blood Bank. "Obtaining FACT Accreditation for cord blood collection, processing, testing, banking, selection and release of unrelated allogeneic cord blood units validates the high quality procedures which CORD:USE and our world-class team utilize. This accreditation gives additional assurance to transplant physicians when choosing our units for their patients."

FACT is considered by many transplanters to be the premier accreditation organization in the cord blood banking industry. FACT is a non-profit, voluntary organization that develops, maintains and updates comprehensive standards for all aspects of cord blood collection, processing and transplantation. The process includes an examination and inspection from international panels of cord blood experts and at least one transplant physician. The examination team reviews all aspects of the cord blood banking process. Only those companies with consistent, well-documented processes that meet the standards developed by FACT in all areas are eligible for accreditation.

"We are extremely proud to be one of the elite cord blood banks worldwide who has met the stringent processes standards required for FACT accreditation and that provides the highest quality cord blood units for patients in need of potentially life-saving transplants," says Dr. Guindi.

About CORD:USE Cord Blood Bank

CORD:USE Cord Blood Bank, headquartered in Orlando, Florida, is creating a large, ethnically diverse, high quality inventory of available cord blood stem cell units for the many patients in need of a potentially life-saving transplant. CORD:USE has entered into agreements with hospitals across the country to provide mothers the option to donate their babies' cord blood. CORD:USE makes these cord blood units available to transplanters throughout the country and around the world, as a critical component in their patients' treatment. CORD:USE lists all of its units on the National Marrow Donor Program's Registry. For more information, please visit www.corduse.com.


'/>"/>
SOURCE CORD:USE Cord Blood Bank
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Specific antagonism lowers blood pressure
2. Restricting Blood Flow May Help Heart Bypass Patients
3. FDA Updates Prescription Guidelines for Blood Thinner
4. Doctors Often Miss High Blood Pressure in Kids
5. Back to School Means Return of School Blood Drives
6. Blood-flow detector software show promise in preventing brain damage
7. FDA Approves New Roche West Nile Virus Blood Screening Test
8. Australian-led international study shows blood pressure drugs cut death rate in type 2 diabetes
9. Laser blasts viruses in blood
10. Study Demonstrates Marteks Algal DHA Oil Improves Blood Triglyceride Lipid Levels
11. LifeMasters Provides Tips for Maintaining a Healthy Blood Cholesterol Level
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/22/2017)... ... February 22, 2017 , ... ... absorption cannabidiol (CBD) serum, “NANOCALM 300” Microemulsified Hemp Extract. This premier nanoemulsified ... from the mouth into the bloodstream. Far outpacing the absorption speed ...
(Date:2/22/2017)... (PRWEB) , ... February 22, 2017 , ... ANGLESTRONG ... Kurt Angle, is now available on the App Store and Google ... mobile apps for the addiction and recovery industry, partnered with Angle to build ANGLESTRONG. ...
(Date:2/22/2017)... (PRWEB) , ... February 22, 2017 , ... ... launch of ProGen™ PRP, the latest innovation in the delivery of Platelet Rich ... care, aesthetics, cardiovascular and pain management, to accelerate tissue synthesis and provide a ...
(Date:2/22/2017)... Switzerland (PRWEB) , ... February 22, 2017 , ... ... difficulty hearing and 72 percent of those report that family members or friends ... who think they suffer from hearing loss wear hearing aids. One reason, suggested ...
(Date:2/22/2017)... Carolina (PRWEB) , ... February 22, 2017 , ... Pet ... cats and 54% of dogs, according to the Association for Pet Obesity Prevention (APOP). ... on key pet food issues such as the benefits of corn and grains, value ...
Breaking Medicine News(10 mins):
(Date:2/23/2017)... 22, 2017 Orthopedic and cardiac devices ... aging demographic patterns lead to an increasing prevalence ... and exercise-related injuries, chronic back problems, heart valve ... gains. The future of medical implants faces many ... questions and more: - What types of ...
(Date:2/23/2017)... 23, 2017  CTI BioPharma Corp. (CTI BioPharma) (NASDAQ ... report its fourth quarter and full year 2016 financial ... the U.S. financial markets. Following the announcement, members of ... to discuss the results and provide a general corporate ... event can be obtained as follows: Thursday, ...
(Date:2/22/2017)... Calif. , Feb. 22, 2017 IRIDEX ... it will release financial results for the fourth quarter ... March 8, 2017.  The Company,s management team will host ... / 5:00 p.m. ET. Investors interested in ... dialing (844) 707-0665 for domestic callers or (703) 326-3030 ...
Breaking Medicine Technology: